Genetic identification of Mycobacterium bovis BCG by restriction fragment length polymorphism analysis of the direct-repeat region

Journal of Clinical Microbiology

Volumn 35, Issue 4, 1997, Pages 965-968

  Howard, S T ^a,b   Laszlo, A ^a   Johnson, W M ^a  

^a Bureau of Microbiology   (Canada)

^b LAB CENTRE FOR DISEASE CONTROL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BACTERIAL GENE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; MYCOBACTERIOSIS; MYCOBACTERIUM BOVIS; NONHUMAN; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; STRAIN DIFFERENCE;

BACTERIA (MICROORGANISMS); MYCOBACTERIUM; MYCOBACTERIUM BOVIS BCG; MYCOBACTERIUM TUBERCULOSIS;

EID: 0031004294     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.35.4.965-968.1997     Document Type: Article

References (29)

1. Abou-Zeid, C., M. Harboe, and G. A. W. Rook. 1987. Characterization of the secreted antigens of Mycobacterium bovis BCG: comparison of the 46-kilo-dalton dimeric protein with proteins MPB64 and MPB70. Infect. Immun. 55:3213-3214.
2. Abou-Zeid, C., I. Smith, J. Grange, J. Steele, and G. Rook. 1986. Subdivision of daughter strains of bacille Calmette-Guérin (BCG) according to secreted protein patterns. J. Gen. Microbiol. 132:3047-3053.
3. Brosman, S. A., and D. L. Lamm. 1990. The preparation, handling and use of intravesical bacillus Calmette-Guérin for the management of stage Ta, T1, carcinoma in situ and transitional cell cancer. J. Urol. 144:313-315.
4. Collins, D. M., and G. W. De Lisle. 1987. BCG identification by DNA restriction fragment patterns. J. Gen. Microbiol. 133:1431-1434.
5. Das, S., C. N. Paramasivan, D. B. Lowrie, R. Prabhakar, and P. R. Narayanan. 1995.IS6110 restriction fragment length polymorphism typing of clinical isolates of Mycobacterium tuberculosis from patients with pulmonary tuberculosis in Madras, South India. Tubercle Lung Dis. 76:550-554.
6. Floyd, M. M., V. A. Silcox, W. D. Jones, Jr., W. R. Butler, and J. O. Kilburn. 1992. Separation of Mycobacterium bovis BCG from Mycobacterium tuberculosis and Mycobacterium bovis by using high-performance liquid chromatography of mycolic acids. J. Clin. Microbiol. 30:1327-1330.
7. Fomukong, N. G., J. W. Dale, T. W. Osborn, and J. M. Grange. 1992. Use of gene probes based on the insertion sequence IS986 to differentiate between BCG vaccine strains. J. Appl. Bacteriol. 72:126-133.
8. Frothingham, R. 1995. Differentiation of strains in Mycobacterium tuberculosis complex by DNA sequence polymorphisms, including rapid identification of M. bovis BCG. J. Clin. Microbiol. 33:840-844.
9. Hermans, P. W. M., D. van Soolingen, E. M. Bik, P. E. W. de Haas, J. W. Dale, and J. D. A. van Embden. 1991. The insertion element IS987 from Mycobacterium bovis BCG is located in a hot-spot integration region for insertion elements in Mycobacterium tuberculosis complex strains. Infect. Immun. 59:2695-2705.
10. Hermans, P. W. M., D. van Soolingen, J. W. Dale, A. R. J. Schuitema, R. A. McAdam, D. Catty, and J. D. A. van Embden. 1990. Insertion element IS986 from Mycobacterium tuberculosis: a useful tool for diagnosis and epidemiology of tuberculosis. J. Clin. Microbiol. 28:2051-2058.
11. Howard, S. T. Unpublished data.
12. Huebner, R. E., and G. W. Comstock. 1994. BCG vaccine, p. 335-348. In L. N. Friedman (ed.), Tuberculosis: current concepts and treatment. CRC Press, Inc., Boca Raton, Fla.
13. Huh, Y. J., D. I. Ahn, and S. J. Kim. 1995. Limited variation of DNA fingerprints (IS6110 and IS1081) in Korean strains of Mycobacterium tuberculosis. Tubercle Lung Dis. 76:324-329.
14. Kent, P. T., and G. P. Kubica. 1985. Public health mycobacteriology, a guide for the level III laboratory. Centers for Disease Control, Public Health Service, U.S. Department of Health and Human Services, Atlanta, Ga.
15. Kröger, L., M. Korppi, E. Brander, H. Kröger, O. Wasz-Höckert, A. Backman, J. Rapola, K. Launiala, and M.-L. Katila. 1995. Osteitis caused by bacille Calmette-Guérin vaccination: a retrospective analysis of 222 cases. J. Infect. Dis. 172:574-576.
16. Li, H., J. C. Ulstrup, T. Ø. Jonassen, K. Melby, S. Nagai, and M. Harboe. 1993. Evidence for absence of the MPB64 gene in some substrains of Mycobacterium bovis BCG. Infect. Immun. 61:1730-1734.
17. Miura, K., S. Nagai, M. Kinomoto, S. Haga, and T. Tokunaga. 1983. Comparative studies with various substrains of Mycobacterium bovis BCG on the production of an antigenic protein, MPB70. Infect. Immun. 39:540-545.
18. Osborn, T. W. 1983. Changes in BCG strains. Tubercle 64:1-13.
19. Pansadoro, V., P. Emiliozzi, L. Defidio, D. Donadio, A. Florio, S. Maurelli, S. Lauretti, and C. N. Sternberg. 1995. Bacillus Calmette-Guérin in the treatment of stage T1 grade 3 transitional cell carcinoma of the bladder: long-term results. J. Urol. 154:2054-2058.
20. Rosenthal, S. R. 1980. BCG in cancer and leukemia, p. 295-324. In S. R. Rosenthal (ed.), BCG vaccine: tuberculosis-cancer. PSG Publishing Company, Inc., Littleton, Mass.
21. Small, P. M., P. C. Hopewell, S. P. Singh, A. Paz, J. Parsonnet, D. C. Ruston, G. F. Schecter, C. L. Daley, and G, K. Schoolnik. 1994. The epidemiology of tuberculosis in San Francisco: a population-based study using conventional and molecular methods. N. Engl. J. Med. 330:1703-1709.
22. Speert, D. P. 1995. The use of bacille Calmette-Guérin vaccination in children. Can. J. Infect. Dis. 6:232-233.
23. ten Dam, H. G. 1995. BCG vaccination: an old idea revisited, p. 109-128. In M. D. Rossman and R. R. MacGregor (ed.), Tuberculosis: clinical management and new challenges. McGraw-Hill, Inc., New York, N.Y.
24. van Deutekom, H., Y. M. Smulders, K. J. Roozendaal, and D. van Soolingen. 1996. Bacille Calmette-Guérin (BCG) meningitis in an AIDS patient 12 years after vaccination with BCG. Clin. Infect. Dis. 22:870-871.
25. van Embden, J. D. A., M. D. Cave, J. T. Crawford, J. W. Dale, K. D. Eisenach, B. Gicquel, P. Hermans, C. Martin, R. McAdam, T. M. Shinnick, and P. M. Small. 1993. Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations tor a standardized methodology. J. Clin. Microbiol. 31:406-409.
26. van Soolingen, D., P. E. W. de Haas, P. W. M. Hermans, P. M. A. Groenen, and J. D. A. van Embden. 1993. Comparison of various repetitive DNA elements as genetic markers for strain differentiation and epidemiology of Mycobacterium tuberculosis. J. Clin. Microbiol. 31:1987-1995.
27. van Soolingen, D., P. W. M. Hermans, P. E. W. de Haas, and J. D. A. van Embden. 1992. Insertion element IS1081-associated restriction fragment length polymorphisms in Mycobacterium tuberculosis complex species: a reliable tool for recognizing Mycobacterium bovis BCG. J. Clin. Microbiol. 30:1772-1777.
28. van Soolingen, D., P. W. M. Hermans, P. E. W. de Haas, D. R. Soll, and J. D. A. van Embden. 1991. Occurrence and stability of insertion sequences in Mycobacterium tuberculosis complex strains: evaluation of an insertion sequence-dependent DNA polymorphism as a tool in the epidemiology of tuberculosis. J. Clin. Microbiol. 29:2578-2586.
29. Zhang, Y., R. J. Wallace, and G. H. Mazurek. 1995. Genetic differences between BCG substrains. Tubercle Lung Dis. 76:43-50.